Crohn's Archives -

In the highly competitive market for inflammatory diseases such as Crohn’s, pharma companies are looking for ways to

Janssen trials ultrasound-guided approach to treating Crohn’s

https://pharmaphorum.com/news/janssen-trials-ultrasound-guided-approach-to-treating-crohns/

J&J unit’s blockbuster gets new use.

EU approval for Crohn’s another boost for fast-growing Stelara

https://pharmaphorum.com/news/janssens-stelara-approved-eu-crohns/

Amgen gets share of $1.5 billion deal

AZ sells potential Crohn’s drug to Allergan

https://pharmaphorum.com/news/az-sells-potential-crohns-drug-allergan/

New use for patients who fail anti-TNF drugs

Stelara gains US approval for Crohn’s disease

https://pharmaphorum.com/news/stelara-crohns/

Analysts left guessing from snippet of early phase data.

Celgene baffles market with Crohn’s drug data

https://pharmaphorum.com/news/celgene-baffles-market-crohns-drug-data/

Crohn’s